Absorption |
Blood-Brain Barrier | BBB- | 0.6221 |
Human Intestinal Absorption | HIA+ | 0.6724 |
Caco-2 Permeability | Caco2- | 0.6608 |
P-glycoprotein Substrate | Substrate | 0.6856 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6604 |
Non-inhibitor | 0.9531 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7931 |
Distribution |
Subcellular localization | Mitochondria | 0.6009 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7739 |
CYP450 2D6 Substrate | Non-substrate | 0.7954 |
CYP450 3A4 Substrate | Non-substrate | 0.5390 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7157 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8009 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8740 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7809 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9029 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9172 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Strong inhibitor | 0.8183 |
Inhibitor | 0.7905 |
AMES Toxicity | Non AMES toxic | 0.6713 |
Carcinogens | Non-carcinogens | 0.5629 |
Fish Toxicity | High FHMT | 0.9774 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8398 |
Honey Bee Toxicity | Low HBT | 0.5576 |
Biodegradation | Not ready biodegradable | 0.6191 |
Acute Oral Toxicity | III | 0.6384 |
Carcinogenicity (Three-class) | Non-required | 0.6916 |